M&A

News

AI medtech specialist Firefly lists on Nasdaq after merger

Canada's Firefly Neuroscience has completed a listing on the Nasdaq via a $45 million reverse merger with IT group WaveDancer, opening up new financing routes for its artificial intelligenc

News

dialysis machine at patient hospital bedside

Baxter slims down again, selling kidney division to Carlyle

Baxter International has agreed to sell its kidney treatment division to private equity firm Carlyle Group in a $3.8 billion cash deal, continuing its efforts to streamline its operations a

News

Recursion Pharma and Exscientia company logos

AI biotechs Exscientia and Recursion agree $688m merger

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued

News

A pair of spectacles in front of computer screens

Does Roche have buyer's remorse for Flatiron takeover?

Roche is reported to be considering the sale of its cancer data specialist Flatiron Health, just a few years after it bought the company for $1.9 billion.

News

Mallinckrodt sells Therakos unit on at a discount

Ireland-headquartered pharma group Mallinckrodt has agreed to divest its subsidiary Therakos to private equity firm CVC Capital Partners for $925 million, well below the $1.33 billion it pa

News

Anne Wojcicki, CEO and co-founder of 23andMe

23andMe board rebuffs CEO plan to take the firm private

A proposal by 23andMe founder and chief executive Anne Wojcicki to take the genetic testing company private has been rejected by a special committee of the board of directors.

AI medtech specialist Firefly lists on Nasdaq after merger

Baxter slims down again, selling kidney division to Carlyle

AI biotechs Exscientia and Recursion agree $688m merger

Does Roche have buyer's remorse for Flatiron takeover?

Mallinckrodt sells Therakos unit on at a discount

23andMe board rebuffs CEO plan to take the firm private

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

M&A

Editor's Picks